Synapticure selected to provide dementia care to Medicare patients in CMS’s GUIDE model
Learn more
For Patients & Families
Getting Started
How It Works
Frequently Asked Questions
Learn more about the CMS GUIDE program
Our Services
Cognitive Care
Alzheimer's Disease
Frontotemporal Dementia
Lewy Body Dementia
All Services...
Movement Care
Parkinson's Disease
Huntington's Disease
All Services...
Neuromuscular Care
Amyotrophic Lateral Sclerosis
Primary Lateral Sclerosis
All Services...
Mental Health Care
All Services...
Care Coordination
Insurance Management & Prior Authorization
Proactive Genetic Testing & Counseling
Clinical Trials & Investigational Therapies
For Partners
Who We Work With
Providers
Payers
GUIDE
Research
Learn more about the CMS GUIDE program
Resources
Content & Media
Our Blog
Press Releases
Movement Care
Parkinson's Disease
Huntington's Disease
All Services...
About Us
Who We Are
Our Story
Leadership Team
Our Clinicians
Company
Careers
Collaborators & Supporters
Contact Us
All Services...
Care Coordination
Insurance Management & Prior Authorization
Proactive Genetic Testing & Counseling
Clinical Trials & Investigational Therapies
Login
Book your visit
Call us to book
(855) 255-5917
Author
Sandra Abrevaya
February 9, 2024
Announcing a New Advisory Relationship with The Michael J. Fox Foundation
Synapticure announces The Michael J. Fox Foundation as its newest advisor to help improve access to specialty care and to accelerate Parkinson’s research
February 9, 2024
Synapticure Launches an IRB-Approved Study for Presymptomatic Carriers of Pathogenic, ALS-Associated Gene Variants
February 9, 2024
Synapticure Patient Panel - 01/12/23
February 9, 2024
Improving outcomes and accelerating treatments through data-driven, remote, proactive care
February 9, 2024
What does it cost to see a Synapticure MD in-network?
The financial and time stress of ALS is real. We aim to reduce both so you can focus on living
.png)
